ALemtuzumab - Latest Advances

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Journal: The New England journal of medicine

Published: December 09, 2025

Towards practical management of the Marburg variant of multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: November 09, 2025

Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: October 22, 2025

Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 17, 2025

Incidence of Alemtuzumab-Induced Thyroid-Associated Orbitopathy: A Systematic Review and Meta-Analysis.

Journal: Ophthalmic plastic and reconstructive surgery

Published: October 13, 2025

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: September 30, 2025

Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of Immunity.

Journal: Transplantation and cellular therapy

Published: September 27, 2025

Irradiation-Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond-Blackfan Anemia Syndrome Is Well-Tolerated and Effective.

Journal: Pediatric blood & cancer

Published: September 16, 2025

Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell Disease.

Journal: medRxiv : the preprint server for health sciences

Published: September 15, 2025

Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell Disease.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 11, 2025

Epidemiological Overview of Colorectal Cancer in Kidney Transplant Recipients: A Systematic Review.

Journal: Cancers

Published: September 10, 2025

Evaluating the Role of Basiliximab Induction in Simultaneous Liver-Kidney Transplantation: A Multicenter Propensity-Score-Matched Analysis.

Journal: Antibodies (Basel, Switzerland)

Published: September 09, 2025

Filters

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia.

Towards practical management of the Marburg variant of multiple sclerosis.

Towards practical management of the Marburg variant of multiple sclerosis.

Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia.

Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia.

Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.

Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.

Incidence of Alemtuzumab-Induced Thyroid-Associated Orbitopathy: A Systematic Review and Meta-Analysis.

Incidence of Alemtuzumab-Induced Thyroid-Associated Orbitopathy: A Systematic Review and Meta-Analysis.

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

IRIS without PML in MS patients - a case report of IRIS after past alemtuzumab therapy with subsequent oral cladribine treatment and review of the literature.

Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of Immunity.

Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of Immunity.

Irradiation-Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond-Blackfan Anemia Syndrome Is Well-Tolerated and Effective.

Irradiation-Free Reduced Intensity Conditioning Stem Cell Transplantation for Young Patients With Diamond-Blackfan Anemia Syndrome Is Well-Tolerated and Effective.

Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell Disease.

Nonmyeloablative Pentostatin-Cyclophosphamide Preconditioning Improves Rates of Engraftment in Adults Undergoing Haploidentical HCT for Sickle Cell Disease.

Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell Disease.

Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell Disease.

Epidemiological Overview of Colorectal Cancer in Kidney Transplant Recipients: A Systematic Review.

Epidemiological Overview of Colorectal Cancer in Kidney Transplant Recipients: A Systematic Review.

Evaluating the Role of Basiliximab Induction in Simultaneous Liver-Kidney Transplantation: A Multicenter Propensity-Score-Matched Analysis.

Evaluating the Role of Basiliximab Induction in Simultaneous Liver-Kidney Transplantation: A Multicenter Propensity-Score-Matched Analysis.